In my semi-educated opinion, the delay in news about the development of IMU/Merial PPE vaccine has been due to the unexpected (poor) results in trials of Mercks' adenovirus HIV vaccine. It was reported late last year* that the HIV vaccine (using a cold virus as vector) actually increased rates of HIV infection in treated subjects. It would be common sense for Merck/Merial to put a precautionary stop to all adeovirus vaccine (human and animal) work after that result. But every cloud should have a silver lining, and greater understanding of adenovirus vaccine function and behaviour will have been achieved from this research. Its better to identify, understand and fix a problem early on, and so on.
* http://www.msnbc.msn.com/id/21674059/
is news coming, page-2
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.8¢ |
Change
-0.002(4.00%) |
Mkt cap ! $356.9M | |||
| Open | High | Low | Value | Volume |
| 5.0¢ | 5.0¢ | 4.7¢ | $2.298M | 47.86M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 1925982 | 4.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.9¢ | 3452098 | 12 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| IMU (ASX) Chart |